Explore Solid Biosciences’ potential with promising SGT-003 trial results for DMD, strong financials, and market recovery ...

Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic ...

Shares of Solid Biosciences Inc. (NASDAQ:SLDB – Get Free Report) have received an average rating of “Buy” from the twelve brokerages that are presently covering the company, MarketBeat reports.

Solid Biosciences Inc.’s SLDB share price has dipped by 14.97%, which has investors questioning if this is right time to buy.

In this article, we are going to take a look at where Solid Biosciences Inc. (NASDAQ:SLDB) stands against other top insider purchases last month. Will there be a recession? How will new tariffs ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Solid Biosciences (SLDB) announced grants of 43,374 restricted stock units to three newly hired employees. The RSUs vest in four equal ...

CHARLESTOWN, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and ...